The CEO is quietly optimistic re the company prospects. It's unfortunate when a company of this quality is caught up in in shorting, which is fuelled by speculation, misinformation and rumour. One would have that the market regulator would have the kahunas to take care of this type of activity, though it has proven impotent in the past.
Anyhow I hope the CEO's firm focus is on the company activities rather than market peculiarities. We should all have some faith that the market will sort it out.
And CSL's market cap if just ONE of the treatments gets to market? That's around 8x our MC....Be still my beating heart, lest I soon need some Revascor
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.41 |
Change
0.620(34.6%) |
Mkt cap ! $3.084B | |||
| Open | High | Low | Value | Volume |
| $1.90 | $2.48 | $1.90 | $58.82M | 25.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100915 | $2.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.41 | 99 | 1 |
View Market Depth
| Last trade - 16.12pm 18/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |